Izrael - hebrejčina - Ministry of Health

תעשיות ביולוגיות ישראל בית העמק בע"מ - מומחה - לפי הוראות היצרן המאושרות על ידי ivd האירופאים

Izrael - hebrejčina - Ministry of Health

כמיטק - רופא - מכשור כרורגי לבתי חולים

Izrael - hebrejčina - Ministry of Health

medical technological - רופא

Izrael - hebrejčina - Ministry of Health

מדיקל טכנולוג'יקל קו. mtc - רופא

Izrael - hebrejčina - Ministry of Health

raz pharmaceutics ltd, israel - benzydamine hydrochloride - benzydamine hydrochloride 0.15 %w/v - benzydamine

Izrael - hebrejčina - Ministry of Health

abic marketing ltd, israel - levocarnitine - תמיסה - levocarnitine 30 % - levocarnitine - levocarnitine - systemic and myopathic carnitine deficiency.

Izrael - hebrejčina - Ministry of Health

devries & co. ltd - betamethasone - טבליה - betamethasone 0.5 mg - betamethasone - betamethasone - diseases responsive to oral glucocorticosteroid therapy.

Izrael - hebrejčina - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Izrael - hebrejčina - Ministry of Health

taro international ltd, israel - piroxicam as beta-cyclodextrin - טבליה - piroxicam as beta-cyclodextrin 20 mg - piroxicam - piroxicam - piroxicam is indicated for symptomatic relief of osteoarthritis rheumatoid arthritis or ankylosing spondylitis. when an nsaid is indicated piroxicam should be considered as a second line option. the desicion to prescribe piroxocam should be based on an assesment of the individual's patient overall risk.

Izrael - hebrejčina - Ministry of Health

taro international ltd, israel - piroxicam as beta-cyclodextrin - אבקה מסיסה במים - piroxicam as beta-cyclodextrin 20 mg - piroxicam - piroxicam - piroxicam is indicated for symptomatic relief of osteoarthritis rheumatoid arthritis or ankylosing spondylitis. when an nsaid is indicated piroxicam should be considered as a second line option. the desicion to prescribe piroxocam should be based on an assesment of the individual's patient overall risk